You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Johnson and Johnson
AstraZeneca
Express Scripts
Moodys

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Patent: 4,723,946

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 4,723,946
Title: Urinary catheter, hygiene system and process therefor
Abstract:A novel urinary catheter, hygiene unit and daily process for cleansing this catheter while in place within the user\'s bladder. This equipment and process are intended to reduce the occurrence of urinary tract infections and associated sepsis in individuals with chronic, long-term indwelling urinary catheters. Pressurized fluids delivered through a specially configured catheter dislodge, rinse and remove bacteria and bacterial growth medium formed by mucus, crystalline urinary deposits and urinary debris from the inner aspect or urinary lumen of the catheter. Special safety features of the catheter provide for a separation of the inner aspects of the catheter from the bladder lumen while the cleansing process is occuring and prevent attachment of the hygiene unit to the catheter unless this separation is accomplished. These safety features prevent the introduction of cleansing fluids into the user\'s body. The hygiene unit accomplishes this cleansing process by pumping sterile water and cleansing fluids in an orderly predetermined sequence at the required flow rates, volumes and composition. The hygiene unit is equipped with a \"Unit\" function so that it can clean itself and also a safety function, so that it shuts itself off when its fluid reservoirs are empty.
Inventor(s): Kay; Dennis M. (Palm Harbor, FL)
Assignee:
Application Number:06/828,538
Patent Claims:see list of patent claims

Details for Patent 4,723,946

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial 2039-09-23 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial 2039-09-23 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Moodys
Mallinckrodt
Merck
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.